Forbes August 30, 2024
Dr. Sai Balasubramanian, M.D., J.D.

A new study published in the journal Science reports that scientists have created a mask-based device to help monitor biomarkers for certain medical conditions such as COPD and asthma by analyzing chemicals in a wearer’s breath.

Professor Wei Gao and his team, from the California Institute of Technology, have named the device EBCare, which is an abbreviation for “exhaled breath condensate.” Gao explains that “Monitoring a patient’s breath is something that is routinely done, for example, to assess asthma and other respiratory conditions. However, this has required the patient to visit a clinic for sample collection, followed by a waiting period for lab results.” Now, with this new device, users can be monitored over time and remotely to get real-time...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Transforming public health: a physician’s innovative approach [PODCAST]
Trump Nominates Physicians for CDC Director, Surgeon General
5 Things You Should Know About Long COVID
Q&A: How school eligibility influences the spread of infectious diseases
The surprising effect COVID-19 could have on cancer

Share This Article